SMALL CELL
Limited:
Extensive:
NON-SMALL CELL
Stage I:
-
SWOG E5597: Phase III Chemoprevention Trial of
Selenium Supplementation in Persons with Resected Stage
I Non-Small Cell Lung Cancer.
-
CTSU C140503: A Phase III Randomized Trial Of
Lobectomy Versus Sublobar Resection For Small Peripheral
Non-Small Cell Lung Cancer
-
SWOG 0720: Phase II ERCC 1 and RRM1-Based Adjuvant
Therapy Trial in Patients with Stage I Non-Small Cell
Lung Cancer (NSCLC)
Selected:
-
CTSU E1505:
A Phase III Randomized Trial of Adjuvant Chemotherapy With or
Without Bevacizumab for Completely Resected Stage IB-IIIA
Non-Small Cell Lung Cancer (NSCLC)
-
PSOC 6137: A Phase II Study of Intermittent Gleevec ® (Imatinib
mesylate) and Weekly Paclitaxel in Patients Aged 70 or Older
with Advanced Non-small Cell Lung Cancer
Stage III:
-
RTOG 0617: A randomized Phase III Comparison of
Standard-Dose (60 GY) Versus High-dose (74 Gy) Conformal
radiotherapy with concurrent and consolidation
Carboplatin/Paclitaxel +/- Cetuximab (IND#103444) in
patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer
MESOTHELIOMA
BRONCHIOLOALVEOLAR:
-
SWOG 0635: A Phase II Trial of the Combination of
OSI-774 (ERLOTINIB; NSC-718781) and Bevacizumab (Rhumab
VEGF; NSC-704865) in Stage IIIB and IV
Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma
With BAC Features (ADENOBAC)
Lung Cancer, Ancillary Study:
-
SWOG9925: Lung Cancer Specimen Repository Protocol,
Ancillary
STAGE IIIB AND IV:
-
SWOG 0636: A Phase II Trial of the Combination of
OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (RHUMAB
VEGF; NSC 704865) in Never-Smokers With Stage IIIB and
IV Primary NSCLC Adenocarcinomas
For more information on the above clinical
trials:
Cheryl Patz, RN, OCN, CCRC, 360.715.4133
Return to previous page
|